-
1
-
-
0031024171
-
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
-
Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. DrugDeliv. Rev. 1997, 23, 3.
-
(1997)
Adv. DrugDeliv. Rev
, vol.23
, pp. 3
-
-
Lipinski, C.A.1
Lombardo, F.2
Dominy, B.W.3
Feeney, P.J.4
-
2
-
-
46449115901
-
The exploration of macrocycles for drug discovery an underexploited structural class
-
Driggers, E. M.; Hale, S. P.; Lee, J.; Terrett, N. K. The exploration of macrocycles for drug discovery an underexploited structural class. Nat. Rev. Drug Discov. 2008, 7, 608.
-
(2008)
Nat. Rev. Drug Discov
, vol.7
, pp. 608
-
-
Driggers, E.M.1
Hale, S.P.2
Lee, J.3
Terrett, N.K.4
-
3
-
-
77955615249
-
Chemoinformatic analysis of biologically active macrocycles
-
Brandt, W.; Haupt, V. J.; Wessjohann, L. A. Chemoinformatic analysis of biologically active macrocycles. Curr. Top. Med. Chem. 2010, 10, 1361-1379.
-
(2010)
Curr. Top. Med. Chem
, vol.10
, pp. 1361-1379
-
-
Brandt, W.1
Haupt, V.J.2
Wessjohann, L.A.3
-
4
-
-
77955650013
-
Macrocyclic inhibitors of Hsp90
-
Johnson, V. A.; Singh, E. K.; Nazarova, L. A.; Alexander, L. D.; McAlpine, S. R. Macrocyclic inhibitors of Hsp90. Curr. Top. Med. Chem. 2010, 10, 1380-402.
-
(2010)
Curr. Top. Med. Chem
, vol.10
, pp. 1380-402
-
-
Johnson, V.A.1
Singh, E.K.2
Nazarova, L.A.3
Alexander, L.D.4
McAlpine, S.R.5
-
5
-
-
77955600915
-
Advances in the development of macrocyclic inhibitors of hepatitis C virus NS3-4A protease
-
Avolio, S.; Summa, V. Advances in the development of macrocyclic inhibitors of hepatitis C virus NS3-4A protease. Curr. Top. Med. Chem. 2010, 10, 1403-22.
-
(2010)
Curr. Top. Med. Chem
, vol.10
, pp. 1403-1422
-
-
Avolio, S.1
Summa, V.2
-
6
-
-
77955646151
-
Macrocyclic histone deacetylase (HDAC) inhibitors
-
Mwakwari, S. C.; Patil, V.; Guerrant, W.; Oyelere, A. K. Macrocyclic histone deacetylase (HDAC) inhibitors. Curr. Top. Med. Chem. 2010, 10, 1423-40.
-
(2010)
Curr. Top. Med. Chem
, vol.10
, pp. 1423-1440
-
-
Mwakwari, S.C.1
Patil, V.2
Guerrant, W.3
Oyelere, A.K.4
-
7
-
-
77955638589
-
Recent advances in the medicinal chemistry of novel erythromycin-derivatized antibiotics
-
Ying, L.; Tang, D. Recent advances in the medicinal chemistry of novel erythromycin-derivatized antibiotics. Curr. Top. Med. Chem. 2010, 10, 144-169.
-
(2010)
Curr. Top. Med. Chem
, vol.10
, pp. 144-169
-
-
Ying, L.1
Tang, D.2
-
8
-
-
77955625804
-
Macrocycle molecules for the management of systemic infections: The clarithromycin paradigm
-
Giamarellos-Bourboulis, E. J. Macrocycle molecules for the management of systemic infections: the clarithromycin paradigm. Curr. Top. Med. Chem. 2010, 10, 1470-75.
-
(2010)
Curr. Top. Med. Chem
, vol.10
, pp. 1470-1475
-
-
Giamarellos-Bourboulis, E.J.1
|